Gynaecological cancer is the third most commonly diagnosed cancer among women in Australia and accounts for about 8.6% of all cancer deaths in women.1 Projected increases in the number of new cases and improvements in 5-year relative survival rates (59% in 1982-86; 68% in 2007-11)1 have increased the number of gynaecological cancer survivors. A strategic approach is required to improve outcomes for women with gynaecological cancers in Australia and to meet increasing pressures on the health system. Cancer Australia has developed the National Framework for Gynaecological Cancer Control (‘the Framework’) which identifies national priority areas for action across the cancer control continuum, including prevention, screening, diagnosis, treatment, follow-up, supportive and palliative care, and research.
An expert gynaecological cancer advisory group oversaw the development of the Framework. Analyses of epidemiological data, a literature review and national consultations with key stakeholders were conducted. Findings were analysed by the expert advisory group according to the following thematic elements: cancer control continuum; priority population groups; evidence-based practice; and research, evaluation and continuous improvement.
Six national priority areas for action have been identified:
The Framework incorporates evidence-based strategies and allows flexibility for jurisdictions and health service organisations to address each priority within their specific service environment.
Through the development of nationally agreed, evidence-based priority areas in gynaecological cancer control, the Framework will guide national efforts to improve gynaecological cancer outcomes.